ResearcherKyushu UniversityActive in the last 2 years
Masafumi Nakamura
Matched on OpenAlex author ID A5107699407. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 2, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 55
2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 3 papers
Papers 7
- Clinical role of intraperitoneal chemotherapy in patients with pancreatic ductal adenocarcinoma concomitant with occult peritoneal dissemination: A multicenter… Co-author DOI 10.1002/ags3.70001↗
- Prognostic Significance of Desmoplastic Reaction Classification and Its Association With Stromal Biomarkers in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.modpat.2025.100865↗
- uPAR expression in M-MDSCs under high LDHA activity in pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41598-025-29823-4↗
- Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. Co-author DOI 10.1007/s00535-024-02103-0↗
- Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s13046-024-03178-6↗
- Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis. First author DOI 10.1007/s10147-023-02317-x↗
- Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society: A Synopsis. First author DOI 10.1097/mpa.0000000000001513↗
Closest collaborators
The 25 strongest of 55 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kohei Nakata · 4 shared papers, 2024–2025 · strength 0.78
- Paper Prognostic Significance of Desmoplastic Reaction Classification and Its Association With Stromal Biomarkers in Pancreat… DOI 10.1016/j.modpat.2025.100865↗
- Paper uPAR expression in M-MDSCs under high LDHA activity in pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-025-29823-4↗
- Paper Patient-derived organoids of pancreatic ductal adenocarcinoma for subtype determination and clinical outcome prediction. DOI 10.1007/s00535-024-02103-0↗
- Yoshinao Oda · 3 shared papers, 2024–2025 · strength 0.61
- Paper Prognostic Significance of Desmoplastic Reaction Classification and Its Association With Stromal Biomarkers in Pancreat… DOI 10.1016/j.modpat.2025.100865↗
- Paper uPAR expression in M-MDSCs under high LDHA activity in pancreatic ductal adenocarcinoma. DOI 10.1038/s41598-025-29823-4↗
- Paper Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreat… DOI 10.1186/s13046-024-03178-6↗
- Koji Shindo · 2 shared papers, 2024–2025 · strength 0.40
- Paper Prognostic Significance of Desmoplastic Reaction Classification and Its Association With Stromal Biomarkers in Pancreat… DOI 10.1016/j.modpat.2025.100865↗
- Paper Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreat… DOI 10.1186/s13046-024-03178-6↗
- Chika Iwamoto · 2 shared papers, 2024–2025 · strength 0.37
- Chikanori Tsutsumi · 2 shared papers, 2024–2025 · strength 0.37
- Kenoki Ohuchida · 2 shared papers, 2024–2025 · strength 0.37
- Naoki Ikenaga · 2 shared papers, 2024–2025 · strength 0.37
- Shoko Noguchi · 1 shared paper, 2025 · strength 0.24
- Takashi Matsumoto · 1 shared paper, 2025 · strength 0.24
- Kousei Ishigami · 1 shared paper, 2025 · strength 0.24
- Nobuhiro Fujita · 1 shared paper, 2025 · strength 0.24
- Bo Zhang · 1 shared paper, 2025 · strength 0.20
- Yusuke Mizuuchi · 1 shared paper, 2025 · strength 0.20
- Hideya Onishi · 1 shared paper, 2025 · strength 0.20
- Katsuhito Teramatsu · 1 shared paper, 2024 · strength 0.17
- Masatoshi Murakami · 1 shared paper, 2024 · strength 0.17
- Kazuhide Matsumoto · 1 shared paper, 2024 · strength 0.17
- Akihisa Ohno · 1 shared paper, 2024 · strength 0.17
- Yoshinao Oda · 1 shared paper, 2024 · strength 0.17
- Nao Fujimori · 1 shared paper, 2024 · strength 0.17
- Yoshihiro Ogawa · 1 shared paper, 2024 · strength 0.17
- Masataka Hayashi · 1 shared paper, 2024 · strength 0.17
- Toshiya Abe · 1 shared paper, 2024 · strength 0.17
- Noboru Ideno · 1 shared paper, 2024 · strength 0.17
- Koki Oyama · 1 shared paper, 2024 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.